A host
of new clinical studies have found that specific dietary practices can significantly improve memory function in patients with Alzheimer's...
Five hundred cancer patients are getting an in - depth look at their genomes as part
of a new clinical study that is revealing some of the key molecular drivers of metastatic cancers.
Not exact matches
Novo is advancing its
clinical study of its next big hope in treating obesity: semaglutide, a
new drug in the so - called GLP - 1 category which imitates an intestinal hormone that stimulates the production
of insulin.
In health care, this amounts to an hourly avalanche
of new research papers,
clinical trials, scientific
studies, and patient health information.
«It also brings in the question
of diet,» says Wargo, who is now working on
new clinical studies on the microbiome with the Parker Institute for Cancer Immunotherapy.
«It's all about shaping the child's behavior,» says Dr. Andrea Vazzana,
clinical assistant professor
of child psychiatry at
New York University Langone's Child
Study Center.
Currently in the U.K., he will go back to Privateer's headquarters in Seattle, then visit Tilray's 60,000 - square foot facilities in British Columbia, Canada, then to Australia, where Tilray has an import license to send marijuana for a
clinical trial with a chemotherapy - induced nausea and vomiting
study with the University
of Sydney, the government
of New South Wales and the country's largest cancer hospital.
I'm not alone in having a hard time hearing what my gut has to say when I'm already anxious, something a
new study published in
Clinical Psychological Science supports: researchers from the University
of Basel and the Berlin Psychological University found that anxiety may impair your ability to listen to your intuition.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for
new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from
clinical trials involving investigational compounds; Gilead's ability to initiate
clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit
new drug applications for
new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for
new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from
clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
For BTN's 2016 Corporate Travel Index, the 32nd annual, BCD Travel's Advito provided the average hotel and car rental costs paid by BCD corporate clients, BTN collected hotel taxes and surcharges from hotels, and eight
New York University School
of Professional
Studies Advanced Research Seminar students, led by academic chair and
clinical assistant professor Lynn Minnaert, called restaurants in October and November to gather meal prices.
Under the direction
of Lynn Minnaert, academic chair and
clinical associate professor in the Jonathan M. Tisch Center for Hospitality and Tourism, part
of the
New York University School
of Professional
Studies, eight students called restaurants in 200 cities from January 2018 to February 2018 to gather meal prices.
Yet what attracted the most attention was a
new deal with General Electric (NYSE: GE) under which GE's healthcare unit will help fund a
clinical study of flurpiridaz F 18, which the companies believe could help improve diagnosis
of coronary artery disease.
Mar. 18, 2013 — People suffering from complicated grief may have difficulty recalling specific events from their past or imagining specific events in the future, but not when those events involve the partner they lost, according to a
new study published in
Clinical Psychological Science, a journal
of the Association for Psychological Science.
In 2010, researchers from the University
of Michigan Comprehensive Cancer Center published a
study in the journal
Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth
of new tumor cells.
Now, a
new clinical study indicates that rice protein can do the job just as well, and without the potential
of allergic reaction.
A
new clinical study has confirmed the positive effects
of Lipogen PMS ™, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms.
Lisa DiCaprio — Associate Director
of Curriculum,
Clinical Associate Professor
of Social Sciences - Paul McGhee Division
New York University School
of Continuing and Professional
Studies
Since the neuronal death can be recapitulated in directly reprogrammed patient neurons, Yoo said the
new technique offers a way to
study the details
of how potential therapies — including drugs that are currently being tested in
clinical trials — could rescue medium spiny neurons from death.
An unborn child's gender can affect the mother's risk
of developing gestational diabetes or Type 2 diabetes later in life, according to a
new study published in the Endocrine Society's Journal
of Clinical Endocrinology & Metabolism.
What's
new in the Czech
study, explains pathologist Carol Meteyer
of the U.S. Geological Survey's National Wildlife Health Center in Madison, Wisc., is the confirmation
of tissue damage characteristic
of clinical white - nose sydrome: skin being digested by the pathogen as the fungi's fibrous segments enter a bat's wing and begin replacing its cells.
The researchers suggest that
new clinical studies are needed to inform doctors treating women for UTIs — especially kidney infections — to look at whether bacterial vaginosis may put some women at greater risk for this severe form
of UTI.
As CRISPR - Cas9 starts to move into
clinical trials, a
new study published in Nature Methods has found that the gene - editing technology can introduce hundreds
of unintended mutations into the genome.
A
clinical study will now be conducted
of the
new treatment, which has been developed in a collaboration between Chalmers University
of Technology, Sahlgrenska University Hospital, the University
of Gothenburg and Integrum.
In a
new study published in the Journal
of Allergy and
Clinical Immunology, Paller, the Northwestern Medicine chair
of dermatology, together with Dr. Emma Guttman - Yassky
of Mount Sinai Medical School, discovered that an arm
of the immune system — the Th17 pathway — in these patients is way too active, and the higher its activity, the worse the disease severity.
The findings can prompt development
of innovative therapies and
new clinical studies that capitalize on the mechanisms
of MAPK inhibitor addiction.
Vitamin B12 supplements offer no benefits for neurological or cognitive function in older people with moderate vitamin B12 deficiency, according to a
new study published in the American Journal
of Clinical Nutrition.
A diagnosis
of obstructive sleep apnea may raise the risk
of osteoporosis, particularly among women or older individuals, according to a
new study published in the Endocrine Society's Journal
of Clinical Endocrinology & Metabolism (JCEM).
By taking a high - cost drug with a low - fat meal — instead
of on an empty stomach, as prescribed — prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent, according to a
new study in the March 28, 2018, issue
of the Journal
of Clinical Oncology (JCO).
A one - time intravenous infusion
of the high dose
of gene therapy extended the survival
of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1
clinical trial, according to a
study published in the
New England Journal
of Medicine.
These and other findings from a
new study conducted by researchers at Montefiore Health System and Albert Einstein College
of Medicine
of Yeshiva University, offer the first
clinical recommendations for making diagnostic decisions about headaches in pregnant women.
In creating the
new guidelines, which the organization revisits every couple
of years, the WHO panel considered national guidelines and international guidelines, as well as relevant
clinical studies, says Dr. Siobhan Crowley, who led the WHO's guideline revision process this year.
New analyses
of the published
clinical studies indicate that antimicrobial sutures are effective for preventing surgical site infections (SSIs), and they can result in significant cost savings.
Weight loss surgery can curb alterations in brain activity associated with obesity and improve cognitive function involved in planning, strategizing and organizing, according to a
new study published in the Endocrine Society's Journal
of Clinical Endocrinology & Metabolism (JCEM).
Exposure to cold temperatures can convert white fat tissue from the thighs and belly to beige fat that burns calories for heat, but this biological response is hampered in obese people, according to a
new study published in the Endocrine Society's Journal
of Clinical Endocrinology & Metabolism.
«The results
of the phase III
clinical trial show that a target fusion biopsy detects more clinically significant prostate cancer,» said Art Rastinehad, DO, principal investigator
of the
study and director
of interventonal urologic oncology at North Shore - LIJ's Arthur Smith Institute for Urology, in
New Hyde Park, NY.
In a trio
of studies to be presented at the 57th American Society
of Hematology (ASH) Annual Meeting and Exposition in Orlando, investigators at Dana - Farber Cancer Institute will present the results
of clinical trials showing that
new drug combinations can significantly extend the time in which multiple myeloma is kept in check in patients with relapsed or treatment - resistant forms
of the disease.
A
new clinical study at the University
of Michigan Health System will test the ability
of a once daily dose
of doxycycline to reduce the growth
of small abdominal aortic aneurysms.
People diagnosed with cancer gained 3.34 million years
of life thanks to cancer
clinical trials run by SWOG and supported with public funds, according to new study results to be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research
clinical trials run by SWOG and supported with public funds, according to
new study results to be presented at the 53rd Annual Meeting
of the American Society
of Clinical Oncology (ASCO), the world's largest clinical cancer research
Clinical Oncology (ASCO), the world's largest
clinical cancer research
clinical cancer research meeting.
In a
new study published in the Journal
of Allergy and
Clinical Immunology, researchers have now found a
new principle for how epigenetic changes can occur.
Since 2006, the number
of industry - sponsored
clinical trials
studying the benefits and harms
of medical treatments has risen dramatically, while the number
of clinical trials funded by the National Institutes
of Health (NIH) has fallen substantially, according to
new Johns Hopkins Bloomberg School
of Public Health research.
The REACT (Randomized Evaluation
of an Algorithm for Crohn's Treatment)
study, led by Robarts
Clinical Trials at Western University (London, Canada) provides valuable
new insights for community gastroenterologists which should benefit patients.
«Researchers illuminate key role
of NOX proteins in liver disease:
Study adds credence to
new treatment approach now in
clinical trials.»
Moreover, greater numbers
of Plasmodium parasites correlated with increased rates
of Ebola survival, according to a dozen collaborating research groups in the
new study, published in
Clinical Infectious Diseases.
Since 2004, when she was an undergraduate
studying psychology at the University
of New Mexico, Martinez - Kaigi, who is now a doctoral student in
clinical psychology at the University
of North Texas in Denton, has attended the conference every year that she has been able.
The team behind the
new study looked specifically at the information researchers prepare to justify
clinical trials in humans, which can cost millions
of dollars.
The
new Sierra Leone findings, published in
Clinical Infectious Diseases, are similar to those seen in another
study of Ebola survivors in Guinea during this outbreak and to earlier anecdotal or official reports
of health issues among survivors
of earlier flare - ups.
«We are pleased to have demonstrated such a potent and durable immune response to the vaccine,» said the
study's lead author, Sita Awasthi, PhD, a research associate professor
of Infectious Diseases at Penn. «If found effective in
clinical trials, the vaccine will have a huge impact on reducing the overall prevalence
of genital herpes infections and could reduce
new HIV infections as well, especially in high - burden regions
of sub-Saharan Africa.»
The
new study is a meta - analysis
of three randomized controlled trials conducted by the Alliance for
Clinical Trials in Oncology (formerly Cancer and Leukemia Group B)(CALGB) with support from the NCI, Intergroupe Francophone du Myélome (IFM), and the Gruppo Italiano Malattie Ematologiche dell «Adulto (GIMEMA).
In addition to its
clinical value, the
new study also sheds some light on the nature
of consciousness.
«It's very interesting work but not practical for
clinical treatment
of patients,» says Denis Paré, a neuroscientist at Rutgers University in
New Jersey who is also
studying pharmacological approaches to manipulating fearful memories.